Back to Results
First PageMeta Content
Pharmacology / Science / Clinical research / Nicotinic agonists / Bioethics / Varenicline / Bupropion / Placebo / Nicotine replacement therapy / Medicine / Smoking cessation / Ethics


Public Summary Document – March 2014 PBAC Meeting 7.8 VARENICLINE, tablets, 500 microgram and 1 mg (as tartrate) (titration pack), tablets, 1 mg (as tartrate), Champix®, Pfizer
Add to Reading List

Document Date: 2015-03-23 21:11:42

Open Document

File Size: 472,46 KB

Share Result on Facebook

Company

Gartner / Pfizer Australia Pty Ltd. / QALYs PBN / ITT / /

Country

Australia / /

Currency

USD / /

Event

FDA Phase / /

IndustryTerm

composite / /

MedicalTreatment

cognitive behavioural therapy / nicotine replacement therapy / retreatment / /

Organization

American Medical Association / /

Person

Britton JR / /

Product

Zyban / bupropion hydrochloride / Meeting 7.8 VARENICLINE / nicotine / A3051139 / /

PublishedMedium

Journal of the American Medical Association / /

Technology

Trial Protocol / /

SocialTag